BPC-157 + TB-500 is a synergistic research peptide blend distributed by Peptides Lab UK, formulated for advanced in vitro and pre-clinical studies. This combination includes BPC-157, a synthetic peptide derived from body protection compound, and TB-500, a fragment of thymosin beta-4. Both peptides are individually studied for their effects on tissue regeneration, inflammation modulation, and angiogenesis. When combined, researchers often explore their enhanced potential in cellular repair mechanisms, wound healing models, and musculoskeletal system studies.

Supplied in a high-purity lyophilised format, this peptide combo is HPLC verified at >99% purity, making it a trusted choice for laboratories engaged in molecular biology, peptide signaling, and structure–activity relationship (SAR) investigations.

Product Specifications
– Purity: >99% (HPLC Verified)
– Form: Lyophilised powder
– Storage: Store at -20°C, dry and protected from light
– Solubility: Suitable with sterile water or other approved research solvents

Research Applications
– In vitro studies on tissue regeneration and cell migration
– Molecular investigations on inflammation and cytokine modulation
– SAR studies focusing on peptide synergy in healing processes
– Pre-clinical models for tendon, ligament, and muscle repair

Important Notice
This product is offered by Peptides Lab UK strictly for laboratory research use only. It is not intended for human consumption, medical use, or veterinary application. Only qualified professionals should handle this compound in certified laboratory settings.

>99% Purity Verified | For Laboratory Research Only | Not for Human or Veterinary Use.